Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
AHA 25: MAPLE-HCM Responder Analysis
Author(s): Andrew Wang Added: 3 months ago
AHA Scientific Sessions 2025 – MAPLE-HCM responder analysis shows aficamten monotherapy led to greater treatment effect when compared to metoprolol monotherapy.Dr Andrew Wang (Duke University Medical Center, Durham, NC, US) presents a responder analysis from the MAPLE-HCM trial (NCT05767346), examining clinical responses to aficamten monotherapy versus metoprolol in patients with obstructive… View more

Heart Failure
Non-invasive Coronary Functional Tests in ANOCA
Author(s): Nello Cambise , Angelo Giuseppe Marino , Fabio De Benedetto , et al Added: 2 weeks ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Research Area(s) / Expertise:
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC is the President-Elect of the American Society for Preventive Cardiology. She was a Professor of Medicine and the inaugural Chief of Cardiology at the University of Arizona. Previously, she held the Sarah Ross Soter Chair in Women’s Cardiovascular Health and was the Section Director for Women’s Cardiovascular Health and Preventive Cardiology at The… View more
Importance of Testing for CKD Among Patients With Type 2 Diabetes
Author(s): Pam Taub , Nikolaus Marx Added: 1 year ago
RP-UN-CAR-GB-0166 / June 2024This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical… View more

Guidelines & Statements

Prevention & Chronic Conditions
Lynne Brown
Job title: Associate Director, Clinical Marketing
Lynne Brown is an Associate Director of Clinical Marketing at Philips Healthcare, with responsibility for cardiovascular ultrasound products and advanced imaging technologies. Her work focuses on clinical strategy, education, and product adoption in cardiac imaging, drawing on more than 20 years of experience in echocardiography and clinical ultrasound practice.Professional ExperienceBrown joined… View more
ACURATE neo2 Underexpansion Linked to Poorer Outcomes in ACURATE IDE Trial
Added: 6 months ago Source:  Radcliffe Cardiology
A post hoc analysis of the ACURATE IDE trial has found that underexpansion of the ACURATE neo2 transcatheter heart valve (THV) was associated with a higher rate of adverse clinical outcomes at one year.¹ The original trial failed to demonstrate non-inferiority of the ACURATE neo2 valve compared with contemporary commercial valves for the primary endpoint of all-cause mortality, stroke, or… View more

Imaging & Diagnostics

Intervention
Revascularisation in Patients with Cancer
Author(s): Miguel Nobre Menezes , Mamas A Mamas Added: 2 weeks ago

CV Disease in Special Populations

Intervention
TCT 25: Real-World EVOQUE Outcomes from TVT Registry
Author(s): Raj Makkar Added: 3 months ago
TCT 25 - Dr Raj Makkar (Cedars-Sinai Medical Center, US) joins us to discuss the findings on the EVOQUE Valve (Edwards Lifesciences) drawing from data in the STS/ACC Transcatheter Valve Therapy Registry.The study evaluated procedural success rates, in-hospital complications, and 30-day clinical outcomes in patients undergoing transcatheter tricuspid valve replacement for severe tricuspid… View more

Intervention
TCT 25: Seven-Year Follow-up of the PARTNER 3 Trial
Author(s): Michael J Mack Added: 3 months ago
TCT 2025 - Long-term follow-up of the PARTNER 3 trial showed no safety concerns for transcatheter aortic-valve replacement (TAVR) compared to surgical treatment of aortic stenosis (AS).Dr Michael Mack (Baylor Scott & White Heart Hospital, Plano, US) joins us to share the clinical and echocardiographic outcomes from the seven-year follow-up of the PARTNER 3 low-risk randomised trial (NCT02675114)… View more

Imaging & Diagnostics

Intervention
Ibrutinib, Venetoclax and Adverse Cardiovascular Events
Author(s): Roberta Esposito , Pierantonio Menna , Emanuela Salvatorelli , et al Added: 4 months ago

CV Disease in Special Populations

Prevention & Chronic Conditions